Your Most Pressing Tech Transfer Questions Answered

By Edyta Bartusik-Czubek, PhD, Director of Research and Development; Izabela Kuskowska, Analytical Methods Validation Specialist and Team Leader; and Marta Bednarek, Director of Manufacturing and Operations

The technology transfer marks the crucial stage in drug development when drug sponsors and CDMOs start working together to chart a course towards successful manufacturing. Every tech transfer is distinct, varying depending on the needs of a project and whether it is in early-development, late-stage commercialization, or somewhere in between. As a result, these processes require tailored approaches designed by experienced CDMO teams.

Critical steps to the process include kickoff meetings, detailed information sharing between teams, and thorough risk assessments, which are critical for identifying obstacles and creating mitigation plans. To maximize your chances for a smooth tech transfer, both sponsor and CDMO must commit to continuous communication and transparency; this exercise serves as an opportunity for both teams to build trust and establish a strong working relationship. Interested in exploring what a robust tech transfer should look like? Download the full article to find the answers to your most pressing questions.